
Theravance Biopharma Faces Securities Fraud Investigation Over Failed CYPRESS Trial
Law firm investigating $TBPH for alleged misleading statements about CYPRESS trial and cash burn during enrollment phase that preceded trial failure.
TBPHclass action lawsuitmisleading statements